Please login to the form below

Not currently logged in
Email:
Password:

Daraprim

This page shows the latest Daraprim news and features for those working in and with pharma, biotech and healthcare.

Pfizer gets record £84m fine for hiking price of epilepsy drug

Pfizer gets record £84m fine for hiking price of epilepsy drug

increase for toxoplasmosis drug Daraprim (pyrimethamine) prompted a public outcry and scrutiny of pharma practices last year.

Latest news

More from news
Approximately 4 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Social media and inflation penalties for generic drugs Social media and inflation penalties for generic drugs

    Reaching its zenith with the case of Daraprim and Turing Pharmaceuticals, public outrage surrounding allegations of price gouging helped to expedite government action. ... The US case of Daraprim and Turing. helped to expedite US government action .

  • Pharma deals in September 2015 Pharma deals in September 2015

    Ophthalmic, metabolic, dermatological, autoimmune and anti-infective based deals also featured. The loudest noise, however, was the ricochet created by Turing Pharma's newly acquired, 62 year old drug, daraprim, to

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics